My Buy ZoneMy previous idea was invalidated.
Area $63/$64 which corresponds to the weekly 50 + Fib level 0.382 is my next watch area for a swing.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.09 USD
67.74 M USD
1.54 B USD
66.12 M
About Integra LifeSciences Holdings Corporation
Sector
Industry
CEO
Jan D. de Witte
Website
Headquarters
Princeton
Founded
1989
FIGI
BBG000BZJQL8
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
Earnings and Upgrades Bullish for IART. $70 target Piper Jaffray analyst Matt O'Brien reiterated an Overweight rating and $69 price target on Integra LifeSciences after the company reported Q2 earnings results that were "ahead of expectations," with guidance the analyst believes is "likely conservative." O'Brien was also positive that the company's
Blowoff top in I art - SHORTI am in the market for stocks who have rallied hard and are now extremely overextended and vulnerable to a corrective sell off. IART is one such candidate. Anyone long in this trade is probably in the money and not wanting to lose a good profit. Punters may be wanting to buy hoping for another stron
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
IART5128459
Integra LifeSciences Holdings Corporation 0.5% 15-AUG-2025Yield to maturity
6.37%
Maturity date
Aug 15, 2025
Explore more bonds
Frequently Asked Questions
The current price of IART is 22.13 USD — it has increased by 0.55% in the past 24 hours. Watch Integra LifeSciences Holdings Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Integra LifeSciences Holdings Corporation stocks are traded under the ticker IART.
IART stock has fallen by −6.19% compared to the previous week, the month change is a −4.45% fall, over the last year Integra LifeSciences Holdings Corporation has showed a −50.44% decrease.
We've gathered analysts' opinions on Integra LifeSciences Holdings Corporation future price: according to them, IART price has a max estimate of 35.00 USD and a min estimate of 20.00 USD. Watch IART chart and read a more detailed Integra LifeSciences Holdings Corporation stock forecast: see what analysts think of Integra LifeSciences Holdings Corporation and suggest that you do with its stocks.
IART reached its all-time high on Apr 28, 2021 with the price of 77.40 USD, and its all-time low was 1.36 USD and was reached on Jan 15, 1999. View more price dynamics on IART chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IART stock is 2.04% volatile and has beta coefficient of 1.83. Track Integra LifeSciences Holdings Corporation stock price on the chart and check out the list of the most volatile stocks — is Integra LifeSciences Holdings Corporation there?
Today Integra LifeSciences Holdings Corporation has the market capitalization of 1.70 B, it has decreased by −4.64% over the last week.
Yes, you can track Integra LifeSciences Holdings Corporation financials in yearly and quarterly reports right on TradingView.
Integra LifeSciences Holdings Corporation is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
IART earnings for the last quarter are 0.41 USD per share, whereas the estimation was 0.39 USD resulting in a 5.10% surprise. The estimated earnings for the next quarter are 0.85 USD per share. See more details about Integra LifeSciences Holdings Corporation earnings.
Integra LifeSciences Holdings Corporation revenue for the last quarter amounts to 380.83 M USD, despite the estimated figure of 375.81 M USD. In the next quarter, revenue is expected to reach 445.12 M USD.
IART net income for the last quarter is −10.70 M USD, while the quarter before that showed −12.40 M USD of net income which accounts for 13.76% change. Track more Integra LifeSciences Holdings Corporation financial stats to get the full picture.
No, IART doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 5.33 K employees. See our rating of the largest employees — is Integra LifeSciences Holdings Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Integra LifeSciences Holdings Corporation EBITDA is 279.16 M USD, and current EBITDA margin is 22.32%. See more stats in Integra LifeSciences Holdings Corporation financial statements.
Like other stocks, IART shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Integra LifeSciences Holdings Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Integra LifeSciences Holdings Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Integra LifeSciences Holdings Corporation stock shows the sell signal. See more of Integra LifeSciences Holdings Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.